Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F Peyrade

Showing results (31-40 of 57) with videos related to

Pageof 6
Sort By:
Presse Medicale (Paris, France : 1983)|November 27, 1993
[Rectal Hodgkin's disease in a patient with HIV infection]F Peyrade, P Y Bondiau, J L Peroux, et al.
Sarcoma|June 6, 2008
Very Late Local Relapse of Ewing's Sarcoma of the Head and Neck treated with Aggressive Multimodal TherapyJ Thariat, A Italiano, F Peyrade, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|May 25, 2011
Management of radiation dermatitis in patients receiving cetuximab and radiotherapy for locally advanced squamous cell carcinoma of the head and neck: proposals for a revised grading system and consensus management guidelinesJ Bernier, E G Russi, B Homey, et al.
Presse Medicale (Paris, France : 1983)|April 9, 1994
[Primary adenocarcinoma of the lacrimal glands. A case]P Y Bondiau, X Pivot, F Peyrade, et al.
La Revue De Medecine Interne|May 24, 2003
[Diagnosis of a metastatic valvular tumor in a living patient]C Pulcini, F Vandenbos, E Bernard, et al.
Presse Medicale (Paris, France : 1983)|October 2, 1993
[Bone hydatidosis. Pseudosarcomatous aspect]P Y Bondiau, F Peyrade, I Birswitle, et al.
La Revue De Medecine Interne|April 27, 1999
[Failure of treatment with 2-chlorodeoxyadenosine in the course of hairy cell leukemia associated with malignant histiocytosis]V Jullien, F Peyrade, B Taillan, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|March 1, 2014
Impact of tumor HPV status on outcome in patients with recurrent and/or metastatic squamous cell carcinoma of the head and neck receiving chemotherapy with or without cetuximab: retrospective analysis of the phase III EXTREME trialJ B Vermorken, A Psyrri, R Mesía, et al.
Clinical Oncology (Royal College of Radiologists (Great Britain))|August 12, 2011
Efficacy of cetuximab for unresectable or advanced cutaneous squamous cell carcinoma--a report of eight casesD Giacchero, J Barrière, K Benezery, et al.
Hematological Oncology|July 8, 2017
Description of late onset neutropenia in indolent lymphoma patients treated with bendamustine plus rituximabB Verriere, L Gastaud, E Chamorey, et al.
Pageof 6

Showing results (31-40 of 57) with videos related to

Sort By:
Pageof 6
Presse Medicale (Paris, France : 1983)|November 27, 1993
[Rectal Hodgkin's disease in a patient with HIV infection]F Peyrade, P Y Bondiau, J L Peroux, et al.
Sarcoma|June 6, 2008
Very Late Local Relapse of Ewing's Sarcoma of the Head and Neck treated with Aggressive Multimodal TherapyJ Thariat, A Italiano, F Peyrade, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|May 25, 2011
Management of radiation dermatitis in patients receiving cetuximab and radiotherapy for locally advanced squamous cell carcinoma of the head and neck: proposals for a revised grading system and consensus management guidelinesJ Bernier, E G Russi, B Homey, et al.
Presse Medicale (Paris, France : 1983)|April 9, 1994
[Primary adenocarcinoma of the lacrimal glands. A case]P Y Bondiau, X Pivot, F Peyrade, et al.
La Revue De Medecine Interne|May 24, 2003
[Diagnosis of a metastatic valvular tumor in a living patient]C Pulcini, F Vandenbos, E Bernard, et al.
Presse Medicale (Paris, France : 1983)|October 2, 1993
[Bone hydatidosis. Pseudosarcomatous aspect]P Y Bondiau, F Peyrade, I Birswitle, et al.
La Revue De Medecine Interne|April 27, 1999
[Failure of treatment with 2-chlorodeoxyadenosine in the course of hairy cell leukemia associated with malignant histiocytosis]V Jullien, F Peyrade, B Taillan, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|March 1, 2014
Impact of tumor HPV status on outcome in patients with recurrent and/or metastatic squamous cell carcinoma of the head and neck receiving chemotherapy with or without cetuximab: retrospective analysis of the phase III EXTREME trialJ B Vermorken, A Psyrri, R Mesía, et al.
Clinical Oncology (Royal College of Radiologists (Great Britain))|August 12, 2011
Efficacy of cetuximab for unresectable or advanced cutaneous squamous cell carcinoma--a report of eight casesD Giacchero, J Barrière, K Benezery, et al.
Hematological Oncology|July 8, 2017
Description of late onset neutropenia in indolent lymphoma patients treated with bendamustine plus rituximabB Verriere, L Gastaud, E Chamorey, et al.
Pageof 6